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Dr Spence Taylor (Greenville, SC): Congratulations on a
wonderful presentation and also congratulations on an incredible
effort. This is a real nostalgic presentation for us. In South Caro-
lina, about 15 years ago, the state vascular society attempted this
and actually put 3 years of carotid endarterectomy data together,
accumulated over 1500 carotid endarterectomies, and we did it
almost identical to the way you did it. A lot of the processes that
you presented today were the same processes that we used.
There was a striking difference, however; yours worked, ours
failed. And it failed and lost momentum after about 3 years for
primarily two reasons. We had difficulty maintaining the financial
aspect of the registry, which was a major part, and then second, we
experienced a lack of perceived value, I believe, from the general
practicing private practice surgeon. Time and money, of course, is
a big issue with most practitioners, and I think at the end of the day
they lost the initiative to participate because of a lack of perception
of value.
Even when we, Jay Robison and I, put together the abstract
examining our experience and submitted it to the national and
regional vascular organizations, they did not accept the abstract.
We ended up presenting the data at the Southeastern Surgical
meeting and published it in the American Surgeon.
So, I think we may have been a victim of a different time. And
I think we clearly see what you are doing with this and it is a little
melancholy to see what we could have done. The process improve-
ment potential, as you have shown, may be the greatest part of this
initiative; but, unfortunately, we never got there. I congratulate
you on an outstanding manuscript and an outstanding effort.
Dr Jack L. Cronenwett: I appreciate your remarks. Why has
our registry worked and yours didn’t? There are many reasons why
this worked, but I’ll mention three. First, doing this regionally to
be able to meet together and develop trust was key. I think that
focusing on quality and providing members with feedback that
mattered was important. And I think, finally, getting buy-in from
hospitals that were familiar with this method based on the previous
work of the Northern New England Cardiovascular Disease Study
Group and also getting an initial grant from CMS to allow us toDr John Hallett (Charleston, SC): I have a couple of com-
ments and one question. The first comment is that this regional
quality improvement project would not have happened without Dr
Cronenwett’s leadership. Having been an original member of the
Study Group at Eastern Maine Medical Center, I saw so clearly the
importance of someone with vision and leadership.
Second, your hospital has to invest in a clinical coordinator
and data collector who helps your surgeons get the data recorded.
And finally and most important, Dr Cronenwett has emphasized
that everyone needs to convene twice a year to review the data and
select a few critical items for quality improvement.
My question: how can we take this type of regional quality
improvement model to a national level where others can use a
similar system and then, perhaps, benchmark with this wonderful
database that you have in New England?
Dr Cronenwett: As everyone knows, there are other regis-
tries. The STS has a registry that has been touted by CMS as being
the model for a demonstration project around pay for perfor-
mance. I met with people at CMS here in Baltimore during this
visit, and they believe that this database should qualify, starting in
January, for the physician quality reporting initiative.
There are other good databases like the NSQIP, which is
being rolled out nationally. The advantage of our database is that it
contains a large number of process-specific variables that we think
are going to be important going forward as we try to understand
not only what the results are but why are they different between
hospital A and B. What are the two hospitals doing differently?
Then, how can we make improvement?
So I do think that based on this, there may be an opportunity
for a future roll out of a national vascular database to share
benchmarking data but with regional administration to keep the
size manageable and I am looking into that.
Dr John Ricotta (Stony Brook, NY): I’d like to make a
comment. As maintenance of certification becomes important for
all of us, each of us is going to have to participate in some database
that monitors performance, either NSQIP or some other database,
and this clearly would qualify. My question relates to cost and
where the payment comes from. Many hospitals are already sup-
JOURNAL OF VASCULAR SURGERY
December 20071102 Cronenwett et alporting several databases. Please give us an idea of how to get
hospitals involved in this type of specialty specific activity.
DrCronenwett: I think your comment about maintenance of
certification is important. And as you saw in one of the graphics, we
have hospitals from 25 beds to 600 beds. So you can imagine that
there are many different solutions in each hospital as to how data
are collected. These include surgeon entry of data—exclusively in
some hospitals—to research personnel to nurses on the floor.
Various hospitals have done it different ways. But by and large, the
larger hospitals have committed a part of an FTE to do this and
they have borne that cost.
Now, fortunately, we have had a grant from CMS to do the
central data processing. But I think each hospital has to commit to
local support for data collection. And the hook for that, the way to
attract them, is to start showing them results, to start showing
them how we’re making improvements in length of stay, and how
this process going forward can reduce costs.
Dr George Lavenson (Lahaina, Hawaii): Are there any plans
to include the outcomes from carotid artery stenting as well as
those of carotid endarterectomy? The reason that I ask is that it is
important to ensure that any stenting that is done has results that
are at least equivalent to very safely performed and available end-
arterectomy. In a three-step program for stroke prevention that we
are presenting tomorrow, consisting first of screening and then
diagnosis, the third step is a critical one of assuring that needed
intervention is done safely.
DrCronenwett:That is a good point. And one of the lessons we
have learned from this is don’t try to do too much too fast. But
recognizing where carotid stenting was, we actually began almost 2
years ago also collecting appropriate data on carotid stenting. I didn’t
present that today, but we now have almost 200 such patients in the
registry and we hope to be bringing that forward at another time.Dr Anil Hingorani (Brooklyn, NY): In one of your slides,
there was a 25% incidence of morbidity and mortality on limb loss
and amputations in one of the surgeons who is doing lower
extremity bypasses. How did you get those types of surgeons to
participate and volunteer these data? I don’t see how you would be
able to do that.
DrCronenwett:Well, one of the things that we learned when
we first started presenting these results in a small group setting is
that the surgeons are very interested in improving their results.
Most of them don’t know the details about their results. And when
someone sees a result like that, the response is: “Gee, I see a lot of
people have outstanding results, I want to know how you’re
getting those.”
That’s been our experience. And I think it is because the
surgeons who are doing this are doing it voluntarily, they are
committed to improving, based on their participation, and our
sense is that a surgeon with what appears to be poor outcome is
motivated to do better.
Dr Giovanni Ferrante (Hingham, MA): It sounds like you
have got great buy-in from the surgeons who participated and from
the institutions. But there are at least two other groups at each
institution that may be doing some of these procedures. There
should be motivation on the part of the institutions to include the
interventional radiologists and the cardiologists. Is there any
movement in that direction?
Dr Cronenwett: We have invited anyone who is doing these
procedures to participate. And since we started recording carotid
stent procedures, for example, we now have some cardiologists
who are participating in that phase of the registry. We have a couple
neurosurgeons who are participating around carotid endarterec-
tomy. So yes, we have done that.
